Seminars in Oncology Nursing
Volume 22, Issue 4 , Pages 242-248 , November 2006

Changing Paradigms: Intensity Modulated Radiation Therapy

  • Jennifer C. Cash

      Affiliations

    • Corresponding Author InformationAddress correspondence to Jennifer C. Cash ARNP, MS, OCN, Dattoli Cancer Center and Brachytherapy Research Institute, 2803 Fruitville Road, Suite 1, Sarasota, FL 34237

References 

  1. American Society of Therapeutic Radiation and Oncology (ASTRO) Practicum 2004. Implementing IMRT into clinical practice. 2004;San Diego, CA
  2. Chaiken LM, Steinberg ML. Targeting for cure: Intensity modulated radiation therapy. PCRInsights. 2004;7:2–11
  3. Hong TS, Ritter MA, Tome WA, et al. Intensity-modulated radiation therapy: Emerging cancer treatment technology. Br J Cancer. 2005;92:1819–1824
  4. The BS, Mai WY, Grant WH, et al. Intensity modulated radiotherapy (IMRT) decreases treatment morbidity and potentially enhances tumor control. Cancer Invest. 2002;20:437–451
  5. In: The Oncology Roundtable Clinical Watch (Intensity Modulated Radiation Therapy (IMRT)). 20:Washington, DC: The Advisory Board Company; 2000;p. 1–14
  6. Bucci MK, Bevan MD, Roach M. Advances in radiation therapy: Conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin. 2000;55:117–134
  7. Lynch TJ. Conformal radiation, intensity modulation, and protons. The impact of modern radiotherapy. Medscape coverage of the 10th European Cancer Conference (ECCO 10). www.medscape.com/viewarticle/429361 (accessed Sept 14, 2005).
  8. Mohan R, Low D, Chad S, et al. Intensity modulated radiation treatment planning, quality assurance, delivery and clinical application. In:  Perez C,  Halpern E,  Brady L,  Schmidt-Ullrich R editor. Principles and Practice of Radiation Oncology. Ed 4. Philadelphia, PA: Lippincott, Williams and Wilkins; 2004;p. 314–335
  9. Dattoli MJ, Cash J, Kaltenbach D. Brachytherapy and IMRT. Sarasota, FL: Dattoli Cancer Foundation; 2005;
  10. DeLaney TF, Trofimov AV, Engelsman M, et al. Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas. Cancer Control. 2005;12:27–35
  11. Jones AO, Kleiman MT. Patient setup and verification for intensity-modulated radiation therapy (IMRT). Med Dosim. 2003;28:175–183
  12. Oh OE, Antes K, Darby M, et al. Comparison of 2D conventional, 3D conformal, and intensity modulated treatment planning techniques for patients with prostate cancer with regard to target-dose homogeneity and dose to critical uninvolved structures. Med Dosim. 1999;24:255–263
  13. Dragun AE, Harmon JF, Aguero EG. Defining targets and protecting normal tissues in inverse planned IMRT for prostate, head and neck, and gynecologic cancers: A comparative review. Community Oncol. 2005;2:299–306
  14. Sonnick D, Bhatnagar A, Brandner E, et al. Intensity modulated radiation therapy (IMRT) reduces the dose to the contralateral breast when compared to conventional tangential fields for primary breast irradiation. Int J Radiat Oncol Biol Phys. 2004;60(suppl):s394;(abstr 2100)
  15. Bilsky MH, Yenice K, Lovelock M, et al. Stereotactic intensity modulation radiation therapy for vertebral body and paraspinal tumors. Neurosurg Focus. 2001;11:e7
  16. Wagner H. Image-guided conformal radiation therapy planning and delivery for non small-cell lung cancer. Cancer Control. 2003;10:277–288
  17. Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume and function relationships in parotid salivary glands following conformal and intensity modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45(suppl):s278;(abstr 1043)
  18. Mell LK, Roeske JC, Mundt AJ. A survey of intensity modulated radiation therapy use in the United States. Cancer. 2003;98:204–211

PII: S0749-2081(06)00097-0

doi: 10.1016/j.soncn.2006.07.007

Seminars in Oncology Nursing
Volume 22, Issue 4 , Pages 242-248 , November 2006